Cargando…
Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
BACKGROUND: Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study were to investigate the effects of RCA on thrombin generation, fibrin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967919/ https://www.ncbi.nlm.nih.gov/pubmed/35355147 http://dx.doi.org/10.1186/s13613-022-01004-w |
_version_ | 1784678932061093888 |
---|---|
author | Fisher, Richard Moore, Gary W. Mitchell, Michael J. Dai, Letian Crichton, Siobhan Lumlertgul, Nuttha Ostermann, Marlies |
author_facet | Fisher, Richard Moore, Gary W. Mitchell, Michael J. Dai, Letian Crichton, Siobhan Lumlertgul, Nuttha Ostermann, Marlies |
author_sort | Fisher, Richard |
collection | PubMed |
description | BACKGROUND: Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study were to investigate the effects of RCA on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving CRRT, to compare clotting parameters between systemic and intra-circuit blood samples, and to screen participants for coagulation disorders. We recruited critically ill adult patients admitted to a 30-bedded Intensive care unit in a tertiary care hospital who required CRRT with RCA for acute kidney injury (AKI). Patients with pre-existing thrombotic, bleeding tendencies or a CRRT duration less than 48 h were excluded. We measured coagulation and thrombophilia parameters at baseline. Thrombin generation, D-dimer and platelet function were measured pre-CRRT and at 12, 24, 36, 48 and 72 h after commencing CRRT using blood samples taken from the arterial line and the circuit. RESULTS: At baseline, all eleven patients (mean age 62.4 years, 82% male) had Factor VIII and von Willebrand Factor concentrations above reference range and significantly increased peak thrombin generation. During CRRT, there were no significant changes in systemic maximum peak thrombin generation, time to peak thrombin generation, fibrinogen, D-dimer and platelet function analysis. We observed no significant difference between paired samples taken from the patient's arterial line and the circuit. CONCLUSIONS: Critically ill patients with AKI requiring CRRT are hypercoagulable. Citrate used for anticoagulation during CRRT does not affect thrombin generation, D-dimer or platelet function. Systemic clotting parameters reflect intra-circuit results. Trial registration: ClinicalTrials.gov Identifier: NCT02486614. Registered 01 July 2015—Registered after recruitment of first patient. https://clinicaltrials.gov/ct2/show/NCT02486614 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13613-022-01004-w. |
format | Online Article Text |
id | pubmed-8967919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-89679192022-04-20 Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study Fisher, Richard Moore, Gary W. Mitchell, Michael J. Dai, Letian Crichton, Siobhan Lumlertgul, Nuttha Ostermann, Marlies Ann Intensive Care Research BACKGROUND: Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study were to investigate the effects of RCA on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving CRRT, to compare clotting parameters between systemic and intra-circuit blood samples, and to screen participants for coagulation disorders. We recruited critically ill adult patients admitted to a 30-bedded Intensive care unit in a tertiary care hospital who required CRRT with RCA for acute kidney injury (AKI). Patients with pre-existing thrombotic, bleeding tendencies or a CRRT duration less than 48 h were excluded. We measured coagulation and thrombophilia parameters at baseline. Thrombin generation, D-dimer and platelet function were measured pre-CRRT and at 12, 24, 36, 48 and 72 h after commencing CRRT using blood samples taken from the arterial line and the circuit. RESULTS: At baseline, all eleven patients (mean age 62.4 years, 82% male) had Factor VIII and von Willebrand Factor concentrations above reference range and significantly increased peak thrombin generation. During CRRT, there were no significant changes in systemic maximum peak thrombin generation, time to peak thrombin generation, fibrinogen, D-dimer and platelet function analysis. We observed no significant difference between paired samples taken from the patient's arterial line and the circuit. CONCLUSIONS: Critically ill patients with AKI requiring CRRT are hypercoagulable. Citrate used for anticoagulation during CRRT does not affect thrombin generation, D-dimer or platelet function. Systemic clotting parameters reflect intra-circuit results. Trial registration: ClinicalTrials.gov Identifier: NCT02486614. Registered 01 July 2015—Registered after recruitment of first patient. https://clinicaltrials.gov/ct2/show/NCT02486614 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13613-022-01004-w. Springer International Publishing 2022-03-31 /pmc/articles/PMC8967919/ /pubmed/35355147 http://dx.doi.org/10.1186/s13613-022-01004-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Fisher, Richard Moore, Gary W. Mitchell, Michael J. Dai, Letian Crichton, Siobhan Lumlertgul, Nuttha Ostermann, Marlies Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title | Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title_full | Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title_fullStr | Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title_full_unstemmed | Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title_short | Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
title_sort | effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967919/ https://www.ncbi.nlm.nih.gov/pubmed/35355147 http://dx.doi.org/10.1186/s13613-022-01004-w |
work_keys_str_mv | AT fisherrichard effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT mooregaryw effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT mitchellmichaelj effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT dailetian effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT crichtonsiobhan effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT lumlertgulnuttha effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy AT ostermannmarlies effectsofregionalcitrateanticoagulationonthrombingenerationfibrinolysisandplateletfunctionincriticallyillpatientsreceivingcontinuousrenalreplacementtherapyforacutekidneyinjuryaprospectivestudy |